The estimated Net Worth of Markus Sieger is at least $106 mil dollars as of 20 April 2023. Markus Sieger owns over 59,881 units of Cyclo Therapeutics stock worth over $106,294 and over the last 4 years Markus sold CYTH stock worth over $0.
Markus has made over 4 trades of the Cyclo Therapeutics stock since 2021, according to the Form 4 filled with the SEC. Most recently Markus bought 59,881 units of CYTH stock worth $42,516 on 20 April 2023.
The largest trade Markus's ever made was buying 59,881 units of Cyclo Therapeutics stock on 20 April 2023 worth over $42,516. On average, Markus trades about 4,494 units every 41 days since 2021. As of 20 April 2023 Markus still owns at least 161,051 units of Cyclo Therapeutics stock.
You can see the complete history of Markus Sieger stock trades at the bottom of the page.
Markus's mailing address filed with the SEC is C/O CYCLO THERAPEUTICS, INC., 6714 NW 16TH STREET, SUITE B, GAINESVILLE, FL, 32653.
Over the last 4 years, insiders at Cyclo Therapeutics have traded over $0 worth of Cyclo Therapeutics stock and bought 4,648,141 units worth $6,142,223 . The most active insiders traders include Holdings, Inc. Rafael, Shawn Cross y N Scott Fine. On average, Cyclo Therapeutics executives and independent directors trade stock every 25 days with the average trade being worth of $78,661. The most recent stock trade was executed by Holdings, Inc. Rafael on 1 August 2023, trading 4,000,000 units of CYTH stock currently worth $5,000,000.
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Cyclo Therapeutics executives and other stock owners filed with the SEC include: